Cargando…

Comparing the quality of testing for von Willebrand disease in different geographic localities

Detalles Bibliográficos
Autor principal:	Favaloro, Emmanuel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305405/ https://www.ncbi.nlm.nih.gov/pubmed/35099101 http://dx.doi.org/10.1111/hae.14499

Ejemplares similares

Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies
por: Favaloro, Emmanuel J.
Publicado: (2020)

Letter in response to Colpani et al “A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays”
por: Favaloro, Emmanuel J.
Publicado: (2023)

The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
por: Reardon, Benjamin, et al.
Publicado: (2021)

2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelines
por: Othman, Maha, et al.
Publicado: (2021)

Laboratory diagnosis of von Willebrand disease in the age of the new guidelines: considerations based on geography and resources
por: Favaloro, Emmanuel J., et al.
Publicado: (2023)

The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer
por: Colonne, Chanukya K., et al.
Publicado: (2022)

Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019)

Von Willebrand factor and cancer: Another piece of the puzzle
por: Denis, Cécile V., et al.
Publicado: (2022)

Why is Misdiagnosis of von Willebrand Disease Still Prevalent and How Can We Overcome It? A Focus on Clinical Considerations and Recommendations
por: Colonne, Chanukya K, et al.
Publicado: (2021)

Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device‐induced acquired von Willebrand syndrome
por: Deconinck, Shannen, et al.
Publicado: (2018)

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease
por: Casonato, Alessandra, et al.
Publicado: (2016)

Desmopressin testing in von Willebrand disease: Lowering the burden
por: Heijdra, Jessica M., et al.
Publicado: (2022)

A comparative study in patients with type 2 von Willebrand disease using 4 different platelet-dependent von Willebrand factor assays
por: Colpani, Paola, et al.
Publicado: (2023)

Comparison of 2 ways of performing ristocetin-induced platelet agglutination mixing study for diagnosis of type 2B von Willebrand disease. Response to the publication of Soleimani et al
por: Favaloro, Emmanuel J., et al.
Publicado: (2023)

A Comparative Evaluation of an Automated Functional Assay for Von Willebrand Factor Activity in Type 1 Von Willebrand Disease
por: Lai, Shiue-Wei, et al.
Publicado: (2021)

Von Willebrand Disease: An Overview
por: Bharati, K. Pavani, et al.
Publicado: (2011)

Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease
por: Castaman, Giancarlo
Publicado: (2013)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
por: Manderstedt, Eric, et al.
Publicado: (2018)

Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies
por: Nichols, Timothy C., et al.
Publicado: (2010)

Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
por: Vangenechten, Inge, et al.
Publicado: (2020)

Reply to “Comment on: A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays”
por: Colpani, Paola, et al.
Publicado: (2023)

von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis
por: Kalot, Mohamad A., et al.
Publicado: (2021)

Treatment of patients with von Willebrand disease
por: Tuohy, Emma, et al.
Publicado: (2011)

The Molecular Genetics of von Willebrand Disease
por: Berber, Ergül
Publicado: (2012)

Von Willebrand's Disease: Pathogenesis and Management
por: Dormandy, Katharine M.
Publicado: (1969)

Report on von Willebrand Disease in Malaysia
por: Periayah, Mercy Halleluyah, et al.
Publicado: (2016)

Establishment and characterization of a new and stable collagen-binding assay for the assessment of von Willebrand factor activity
por: Ni, Y, et al.
Publicado: (2013)

Of von Willebrand factor and platelets
por: Bryckaert, Marijke, et al.
Publicado: (2014)

On the Versatility of von Willebrand Factor
por: Rauch, Antoine, et al.
Publicado: (2013)

Commentary on the ASH ISTH NHF WFH 2021 guidelines on the diagnosis of VWD: reflections based on recent contemporary test data
por: Favaloro, Emmanuel J.
Publicado: (2022)

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
por: Leebeek, Frank W. G., et al.
Publicado: (2022)

Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease
por: Boender, Johan, et al.
Publicado: (2021)

Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival
por: Casonato, Alessandra, et al.
Publicado: (2021)

Analysis of von Willebrand Disease in the “Heart of Europe”
por: Vangenechten, Inge, et al.
Publicado: (2022)

Treatment of patients with von Willebrand disease [Erratum]
Publicado: (2013)

Von Willebrand disease in the elderly: clinical perspectives
por: Chapin, John
Publicado: (2018)

Endothelial Function in Patients With Von Willebrand Disease
por: Noone, Stephanie, et al.
Publicado: (2021)

Prophylactic management of patients with von Willebrand disease
por: Franchini, Massimo, et al.
Publicado: (2021)

The Prevalence of von Willebrand Disease and Significance of in Vitro Bleeding Time (PFA-100) in von Willebrand Disease Screening in the İzmir Region
por: Şap, Fatih, et al.
Publicado: (2013)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
por: Gritsch, Herbert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ninh4ei1fr8eve10tn6h008iaf